DIACRIN INC /DE/
10-Q, EX-27, 2000-11-13
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: DIACRIN INC /DE/, 10-Q, 2000-11-13
Next: HAMPSHIRE GROUP LTD, 10-Q, 2000-11-13



<TABLE> <S> <C>

<ARTICLE>                     5
<MULTIPLIER>                  1
<CURRENCY>                    U.S. DOLLARS

<S>                           <C>
<PERIOD-TYPE>                 9-MOS
<FISCAL-YEAR-END>             DEC-31-2000
<PERIOD-START>                JAN-01-2000
<PERIOD-END>                  SEP-30-2000
<EXCHANGE-RATE>               1
<CASH>                        20,711,654
<SECURITIES>                  22,912,965
<RECEIVABLES>                 0
<ALLOWANCES>                  0
<INVENTORY>                   0
<CURRENT-ASSETS>              44,302,401
<PP&E>                        2,029,301
<DEPRECIATION>                1,597,692
<TOTAL-ASSETS>                56,242,897
<CURRENT-LIABILITIES>         1,672,231
<BONDS>                       151,667
<COMMON>                      179,097
         0
                   0
<OTHER-SE>                    54,239,902
<TOTAL-LIABILITY-AND-EQUITY>  56,242,897
<SALES>                       0
<TOTAL-REVENUES>              1,636,757
<CGS>                         0
<TOTAL-COSTS>                 0
<OTHER-EXPENSES>              4,595,952
<LOSS-PROVISION>              0
<INTEREST-EXPENSE>            23,260
<INCOME-PRETAX>               (2,877,017)
<INCOME-TAX>                  0
<INCOME-CONTINUING>           0
<DISCONTINUED>                0
<EXTRAORDINARY>               0
<CHANGES>                     0
<NET-INCOME>                  (2,877,017)
<EPS-BASIC>                 (.17)
<EPS-DILUTED>                 (.17)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission